INKT
INKT
NASDAQ · Biotechnology

Mink Therapeutics Inc

$10.97
-0.05 (-0.45%)
As of Feb 8, 2:18 PM ET ·
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 45.10M 46.49M 39.49M
Net Income 3.70M 3.34M 2.56M
EPS
Profit Margin 8.2% 7.2% 6.5%
Rev Growth +4.3% +20.2% +6.0%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 21.44M 23.91M 26.79M
Total Equity 24.25M 22.68M 23.45M
D/E Ratio 0.88 1.05 1.14
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA 5.80M 5.78M 5.15M
Free Cash Flow 3.02M 2.12M 2.20M